Relationship between central and peripheral fatty acids in humans

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Guest, Jade ^a,b   Garg, Manohar ^c   Bilgin, Ayse ^d   Grant, Ross ^a,b,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY ADVENTIST HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Blood brain barrier; Brain; Cerebrospinal fluid; Fatty acids; Omega 3; Omega 6; Polyunsaturated fatty acids; Whole blood

Indexed keywords

ARACHIDIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; SATURATED FATTY ACID; STEARIC ACID; VACCENIC ACID;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE;

ADULT; CENTRAL NERVOUS SYSTEM; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM;

EID: 84878220173     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-79     Document Type: Article

References (40)

1. Lipid rafts-composition, characterization and controversies. Calder PC, Yaqoob P, J Nutr 2007 137 545 547 17311937
2. Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 cells. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS, J Biol Chem 2001 276 4365 4372 10.1074/jbc.M007273200 11085986
3. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Norris PC, Dennis EA, P Natl Acad Sci USA 2012 109 8517 8522 10.1073/pnas.1200189109
4. Omega-3 fatty acids suppress Th2-associated cytokine gene expressions and GATA transcription factors in mast cells. Park BK, Park S, Park JB, Park MC, Min TS, Jin M, J Nutr Biochem 2012 in Press
5. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/beta-catenin signaling. Song K-S, Jing K, Kim J-S, Yun E-J, Shin S, Seo K-S, Park J-H, Heo J-Y, Kang JX, Suh K-S, Wu T, Park J-II, Kweon G-R, Yoon W-H, Hwang B-D, Lim K, Pancreatology 2012 11 574 584
6. Lipids of nervous tissue: composition and metabolism. Sastry PS, Prog Lipid Res 1985 24 69 176 10.1016/0163-7827(85)90011-6 3916238
7. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. McNamara RK, Carlson SE, Prostag Leukotr Ess 2006 75 329 349 10.1016/j.plefa.2006.07.010
8. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Kawakita E, Hashimoto M, Shido O, Neuroscience 2006 139 991 997 10.1016/j.neuroscience. 2006.01.021 16527422
9. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Akbar M, Calderon F, Wen Z, Kim HY, Proc Natl Acad Sci USA 2005 102 10858 10863 10.1073/pnas.0502903102 16040805
10. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Axelrod J, Biochem Soc Trans 1990 18 503 507 2177403
11. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, Mongrand S, Lay S, J Neurochem 2008 105 296 307 10.1111/j.1471-4159.2007.05129.x 18021297
12. Omega 3 Fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism. Ross BM, Med Hypotheses 2007 68 515 524 10.1016/j.mehy.2006.07.054 17045757
13. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. Astarita G, Jung K-M, Berchtold NC, Nguyen VQ, Gillen DL, Head E, Cotman CW, Piomelli D, PLoS One 2010 5 12538 10.1371/journal.pone.0012538 20838618
14. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. Martín V, Fabelo N, Santpere G, Puig B, Marín R, Ferrer I, Díaz M, J Alzheimer's Dis 2010 19 489 502 23716494
15. Oleic acid synthesized in the periventricular zone promotes axonogenesis in the striatum during brain development. Polo-Hernández E, De Castro F, García-García AG, Tabernero A, Medina JM, J Neurochem 2010 114 1756 1766 10.1111/j.1471-4159.2010.06891.x 20626566
16. Utilization of oleic acid and D-beta-OH-butyrate (D-BOHB) as energy substrates by brain cell cultures of newborn mice at different glucose concentrations. Bossi E, Siegrist HP, Zuppinger K, Wiesmann U, Herschkowitz N, Pediatr Res 1980 14 1417 1417
17. Brain uptake and utilization of fatty acids, lipids & lipoproteins: recommendations for future research. Katz R, Hamilton JA, Pownall HJ, Deckelbaum RJ, Hillard CJ, LeBoeuf RC, Watkins PA, J Mol Neurosci 2007 33 146 150 10.1007/s12031-007-0059-7 17901559
18. Rapid flip-flop of oleic acid across the plasma membrane of adipocytes. Kamp F, Guo W, Souto R, Pilch PF, Corkey BE, Hamilton JA, J Biol Chem 2003 278 7988 7995 10.1074/jbc.M206648200 12499383
19. Localization of mRNA for fatty acid transport protein in developing and mature brain of rats. Utsunomiya A, Owada Y, Yoshimoto T, Kondo H, Mol Brain Res 1997 46 217 222 10.1016/S0169-328X(96)00303-8 9191096
20. Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism. Jumpertz R, Guijarro A, Pratley RE, Mason CC, Piomelli D, Krakoff J, Plos One 2012 7 41503 10.1371/journal.pone. 0041503 22911803
21. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver and serum. Moriguchi T, Loewke J, Garrison M, Catalan N, Salem N, J Lipid Res 2001 42 419 427 11254754
22. Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. Esposito G, Giovacchini G, Liow JS, Bhattacharjee AK, Greenstein D, Schapiro M, Hallett M, Herscovitch P, Eckelman WC, Carson RE, Rapoport SI, J Nucl Med 2008 49 1414 1421 10.2967/jnumed.107.049619 18703605
23. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Carver JD, Benford VJ, Han B, Cantor AB, Brain Res Bull 2001 56 79 85 10.1016/S0361-9230(01)00551-2 11704343
24. Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients. Kale A, Joshi S, Naphade N, Sapkale S, Raju MSVK, Pillai A, Nasrallah H, Mahadik SP, Schizophr Res 2008 98 295 301 10.1016/j.schres.2007.09. 036 17997280
25. Regulation of brain polyunsaturated fatty acid uptake and turnover. Chen CT, Green JT, Orr SK, Bazinet RP, Prostag Leukotr Ess 2008 79 85 91 10.1016/j.plefa.2008.09.003
26. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S, LaFerla F, Bazinet RP, Calon F, Neurochem Int 2009 55 476 482 10.1016/j.neuint.2009.04.018 19442696
27. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. Mitchell RW, On NH, Del Bigio MR, Miller DW, Hatch GM, J Neurochem 2011 117 735 746 21395585
28. Fatty acid transport and utilization for the developing brain. Edmond J, Higa TA, Korsak RA, Bergner EA, Lee W-NP, J Neurochem 1998 70 1227 1234 9489745
29. Fatty acids are synthesized and degraded by different pathways. Berg JM, Tymoczko JL, Stryer L, Biochemistry New York, Freeman WH, 2002 http://www.ncbi.nlm.nih.gov/books/NBK22554/
30. Circadian rhythm of fatty acid desaturation in mouse liver. Actis Dato SM, Catala A, Brenner RR, Lipids 1973 8 1 6 10.1007/BF02533231 4683805
31. Nutritional and hormonal regulation of fatty acid synthase. Wolf G, Nutr Rev 1996 54 122 123 8710241
32. Fatty acid and fatty aldehyde composition of the major brain lipids in normal human grey matter, white matter and myelin. O'Brien JS, Sampson EL, J Lipid Res 1965 6 545 551 5865383
33. Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells. Natali F, Siculella L, Salvati S, Gnoni GV, J Lipid Res 2007 48 1966 1975 10.1194/jlr.M700051-JLR200 17568062
34. Distinct regulation of stearoyl-CoA desaturase 1 gene expression by cis and trans C18:1 fatty acids in human aortic smooth muscle cells. Minville-Walz M, Gresti J, Pichon L, Bellenger S, Bellenger J, Narce M, Rialland M, Genes Nutr 2012 7 209 216 10.1007/s12263-011-0258-2 22057664
35. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP, Science 2000 288 2379 2381 10.1126/science.288.5475. 2379 10875926
36. Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity. Wolfgang MJ, Lane MD, FEBS J 2011 278 552 558 10.1111/j.1742-4658.2010.07978.x 21199367
37. Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. Foster DW, J Clin Invest 2012 122 1958 1959 10.1172/JCI63967 22833869
38. Oleic acid stimulates complete oxidation of fatty acids through PKA-dependent activation of SIRT1/PGC1a complex. Lim J-H, Gerhart-Hines Z, Dominy JE, Lee Y, Kim S, Tabata M, Xiang YK, Puigserver P, J Biol Chem 2013 8 7117 7126
39. Dietary oleic acid not used during brain development and in adult in rat, in contrast with sciatic nerve. Bourre JM, Dumont O, Neurosci Lett 2003 336 180 184 10.1016/S0304-3940(02)01272-7 12505622
40. Direct transesterification of all classes of lipids in a one-step reaction. Lepage G, Roy CC, J Lipid Res 1986 27 114 120 3958609